… modify the effect of LRRK2 mutation. In this study, we aim to replicate and validate our discovery of genes and genetic … our initial genetic findings in participants with the most common type of LRRK2 mutation (p.G2019S) — both people with … how these genetic modifiers influence LRRK2 function in pre-clinical models, we will advance the discovery of new …

… — including Michael J. Fox, Co-Founder Debi Brooks and CEO Todd Sherer — met (virtually) with representatives of the … ideas for better treatments, incentivize researchers and companies, and ramp up the contributions of people living … Parkinson’s. We talked about the current state of research, where there are federal funding gaps, and how we believe …

… The gold-standard diagnosis of PD is confirmed at autopsy. In addition, information on key proteins and cellular … samples. Here, we form an international collaborative group committed to uniform collection, storage and processing of pathological tissues from people with PD who carry LRRK2 mutations. We further aim to collect …

… Team Fox member Tom Kober and his family plan to host their very first Team Fox event this … buffet dinner, golf related prizes, raffles and brief commentary about the day’s primary purposes of not only …

… J. Fox Foundation for Parkinson’s Research’s (MJFF) CEO, Todd Sherer, PhD has been selected to sit on The National … Sciences (NCATS) Advisory Council, providing guidance and recommendations to overcome scientific and systemic barriers … and keep up to date on all of NCATS’ initiatives by visiting the NCATS’ Web site . To read more about Todd …

… time of year that the U.S. House and Senate Appropriations Committees decide how federal dollars will be spent. The … Senate candidates in your state and congressional district. Visit their websites or contact their campaign offices to … CDC and the Department of Defense’s research programs. See where they stand on issues like research freedom, …